MDS, like many other leukemias, is the phenotypic end product of an ordered genetic process occurring in a very specific way in different individuals. Understanding why initiating events are being selected and how they shape the genetic and phenotypic course of the disease is one of the major challenges in leukemia pathogenesis. Professional illustration by Somersault18:24.